RECON DIAGNOSTICS, INC.
NPI 1073191177
Clinical Medical Laboratory in Austin, TX

NPI Status: Active since March 30, 2021

Contact Information

3810 MEDICAL PKWY STE 253
AUSTIN, TX
ZIP 78756
Phone: (240) 240-2125

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 45D2218756
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 05-12-2027

About RECON DIAGNOSTICS, INC.

This page provides the complete NPI Profile along with additional information for Recon Diagnostics, Inc., a provider established in Austin, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1073191177 assigned on March 2021. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated June 2026. The authorized official of this NPI record is Dr. Philip Radford (Owner)

NPI
1073191177
Provider Name
RECON DIAGNOSTICS, INC.
Entity Type
Organization
Location Address
3810 MEDICAL PKWY STE 253 AUSTIN, TX 78756
Location Phone
(240) 240-2125
Mailing Address
907 GATEWAY COMMONS CIR STE 100 WAKE FOREST, NC 27587
Mailing Phone
(240) 240-2125
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
03-30-2021
Last Update Date
06-11-2026
Code Navigator

Establishments like Recon Diagnostics, Inc. are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

DR. PHILIP RADFORD

Authorized Official Title
OWNER
Authorized Official Phone
(240) 240-2125

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection of mycoplasma genitalium by dna or rna probe

This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.

This service was performed 474 times for 370 patients

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus

This test identifies if you have COVID-19, influenza A or B, or respiratory syncytial virus. It uses a multiplex amplified probe technique, which amplifies and detects specific genetic material of the viruses, helping in accurate diagnosis.

This service was performed 11 times for 11 patients

Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique

This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.

This service was performed 76 times for 72 patients

Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique

A detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.

This service was performed 68 times for 58 patients

Detection test by nucleic acid for herpes simplex virus, amplified probe technique

This test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.

This service was performed 388 times for 178 patients

Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique

A detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.

This service was performed 76 times for 72 patients

Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets

This test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.

This service was performed 43 times for 43 patients

Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique

This test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.

This service was performed 76 times for 72 patients

Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique

This is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.

This service was performed 68 times for 58 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 10,942 times for 719 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 357 times for 322 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 467 times for 378 patients

Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique

This test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.

This service was performed 901 times for 707 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 630 times for 494 patients

Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique

This is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.

This service was performed 43 times for 36 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 467 times for 378 patients

Detection test for candida species (yeast), amplified probe technique

This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.

This service was performed 3,200 times for 510 patients

Detection test for gardnerella vaginalis (bacteria), amplified probe technique

This test helps find a specific type of bacteria in the body. It uses a method called the amplified probe technique, which amplifies the bacteria's genetic material, making it easier to detect. It's a standard, pain-free procedure.

This service was performed 32 times for 26 patients

Measurement of dna of bacteria in vaginal fluid specimen

This procedure involves analyzing a sample from the female body to measure the amount of bacterial DNA present. It is a common method used to assess the balance of microorganisms, which is crucial for maintaining good health. It's a simple, non-invasive test.

This service was performed 31 times for 25 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
45D2218756
Facility Type
Independent
Certificate Effective Date
May 13, 2025
Certificate Expiration Date
May 12, 2027
Laboratory Director
DR. ZACHARY J. MESSENGER
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Recon Diagnostics, Inc. on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for RECON DIAGNOSTICS, INC.

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1073191177, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 53. The final step is to find the difference between that total and the next multiple of ten (60 - 53 = 7).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
0
Unchanged
Pos 3
7
Doubled → 14 → 1 + 4
Pos 4
3
Unchanged
Pos 5
1
Doubled → 2
Pos 6
9
Unchanged
Pos 7
1
Doubled → 2
Pos 8
1
Unchanged
Pos 9
7
Doubled → 14 → 1 + 4
Check
7
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 7 → 14 → 5 1 → 2 1 → 2 7 → 14 → 5

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 0 + 1 + 4 + 3 + 2 + 9 + 2 + 1 + 1 + 4 + 24 = 53

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 53 is 60. The difference is the calculated check digit.

60 - 53 = 7
This NPI is valid
The calculated check digit is 7, which matches the last digit of 1073191177.

Other Providers at the Same Location


The following 1 provider is registered at the same or a nearby location.

Pathology (Clinical Laboratory Director, Non-physician)
3810 MEDICAL PKWY STE 253
AUSTIN, TX 78756

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1073191177, enumerated as an "organization" on March 30, 2021.

The provider is located at 3810 MEDICAL PKWY STE 253 AUSTIN, TX 78756 and the phone number is (240) 240-2125.

Clinical Medical Laboratory with taxonomy code 291U00000X.